7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. Dr. Esra Nur Ademoğlu Dilekçi Endocrinology

Prof. Dr. Esra Nur Ademoğlu Dilekçi

✓ Medically verified profile
Endocrinology

Prof. Dr. Esra Nur Ademoğlu Dilekçi

✓ Medically verified profile
27+ years experienceLanguages: Turkish, EnglishOnline consultationAcibadem International Hospital · İstanbul
★★★★★ From 2,400+ verified Acibadem patient reviews
Prof. Dr. Esra Nur Ademoğlu Dilekçi
This Doctor Endocrinology Specialty 27+ Years Experience Acibadem International Hospital Hospital Book an AppointmentBook

Quick answer

Prof. Dr. Esra Nur Ademoğlu Dilekçi is an endocrinology specialist at International Hospital. She treats type 1 and type 2 diabetes, prediabetes, obesity, insulin resistance, and thyroid conditions, including Hashimoto’s disease, thyroid nodules, and thyroid cancer. Her practice also includes thyroid disease evaluation and treatment.

Profile

About Prof. Dr. Esra Nur Ademoğlu Dilekçi

Prof. Dr. Esra Nur Ademoğlu Dilekçi is an endocrinology specialist at International Hospital, providing care for diabetes, prediabetes, obesity, insulin resistance, and thyroid disorders. Her clinical interests include Hashimoto’s disease, thyroid nodules, and thyroid cancer.

She graduated from Gazi University Faculty of Medicine in 1999, completed internal medicine training at Ankara Numune Training and Research Hospital in 2004, and completed endocrinology and metabolic diseases training at Ankara Training and Research Hospital in 2012. Her career has included positions at Bitlis State Hospital, Bolu Abant İzzet Baysal University Faculty of Medicine, Medicana Health Group Kadıköy Hospital, and Acıbadem Healthcare Services.

International patients can expect an endocrinology consultation focused on their individual metabolic or thyroid health concerns. Prof. Dr. Ademoğlu Dilekçi is a member of the European Society of Endocrinology, the Turkish Society of Endocrinology and Metabolism, and the Turkish Obesity Research Association.

Clinical Focus

Areas of Expertise

Conditions treated and procedures performed by this specialist.

Type 1 diabetes treatmentType 2 diabetes treatmentPrediabetesObesityHashimoto’s diseaseInsulin resistanceThyroid disease treatmentThyroid cancerThyroid nodules
Specialisation

Subspecialties

  • Thyroid Diseases and Treatment
Background

Education

  • 2012Ankara Training and Research Hospital Endocrinology and Metabolic Diseases
  • 2004Ankara Numune Training and Research Hospital Internal Medicine
  • 1999Gazi University Faculty of Medicine
Career

Professional Experience

  • 2023Acıbadem Healthcare Services
  • 2021–2023Medicana Health Group-Kadıköy Hospital
  • 2015–2021Bolu Abant İzzet Baysal University Faculty of Medicine
  • 2012–2015Bitlis Devlet Hospital ( mecburi hizmet)
Affiliations

Professional Memberships

  • European Society of Endocrinology (ESE)
  • Turkish Endocrinology and Metabolic Diseases Association
  • Turkey Obesity Research Association
Research

Selected Publications

  • Can the systemic immune-inflammation index be used as a novel diagnostic tool in the diagnosis of subacute thyroiditis? Biomarkers in Medicine. 2022;16(10):791-797. DOI: 10.2217/bmm-2022-0095. Keskin Ç , Dilekçi ENA , Üç ZA , Cengiz D, Duran C.
  • Relationship of glycemic control and diabetes duration with fibromyalgia in patients with type 2 diabetes mellitus J Bionic Mem 2022; 2(3): 87-95 Dilekçi ENA, Dilekçi E , Keskin C, Cengiz D.
  • Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients. Clin Endocrinol (Oxf) 2022 May 31.doi: 10.1111/cen.14787. Yavuz DG, Yazan CD, Hekimsoy, Z, Aydin K, Gokkaya N, Ersoy C, Akalin A, Topaloglu Ö, Aydogan BI, Dilekçi ENA, Üç ZA, Cansu GB, Ozsari L, Iyidir ÖT,
  • The acromegaly registry of ten different centers in Turkey. Growth Hormone and IGF research. 2020; 53-54:101322. DOI: 10.1016/j.ghir.2020.101322. Keskin Ç, Demir Ö, Karcı AC, Berker D, Cantürk Z, Yaylalı GF, Topsakal Ş, Ersoy R, Fahri Bayram F, Ertörer ME, Bozkırlı E, Haydardedeoğlu F, Dilekçi E
  • Evaluation of Platelet Functions in Patients with Hashimoto’s Thyroiditis Versus Healthy Controls: a Cross-Sectional Analysis Clinical Laboratory, 2019;65:953-958. DOI: 10.7754/Clin.Lab.2018.181009. Gorar S, Alioglu B, Dellal FD, Ademoglu E, Uc ZA, Handan Bekdemir H, Saglam B, Culha C, Aral Y.
  • Choroidal vascularity index as a predictor for the development of retinopathy in diabetic patients Journal of Endocrinological Investigation https://doi.org/10.1007/s40618-023-02236-8. C, Dilekci ENA, Ucgul AY, Ucgul YK, Toprak G, Cengiz D.
  • Is circulating survivin altered in acromegaly? DOI: 10.5455/medscience.2017.06.8. Ademoglu E, Dilekçi E, Candan Z, Gorar S, Niyazoglu M, Carlioglu A, Yildiz F, Baydar I, Aslan A.
  • Low levels of circulating platelet factor 4 (PF4, CXCL4) in subclinically hypothyroid autoimmune thyroiditis. Journal of Endocrinological Investigation, 2016; 39(2): 185-9. DOI: 10.1007/s40618-015-0348-x. Gorar S, Ademoglu E, Carlioglu A, Alioglu B, Bekdemir H, Saglam B, Candan Z, Ucler R, Culha C, Aral Y.
  • Higher levels of circulating chemerin in obese women with gestational diabetes Mellitus. Acta Endocrinologica (Bucharest), 2015; 11(1):32-7. DOI: 10.4183/aeb.2015 Ademoglu E, Berberoglu Z, Dellal FD, Ariel MK, Kose A, Candan Z, Bekdemir H, Erdamar H, Culha C, Aral Y.
  • Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome Journal of Endocrinological Investigation, 2014; 37(8): 715-9. DOI: 10.1007/s40618-014-0089-2. Ademoglu E, Gorar S, Carlioglu A, Yazici H, Dellal F D, Berberoglu Z, Akdeniz D, Uysal S, Karakurt F.
Good to Know

Frequently Asked Questions

What is Dr. Esra Nur Ademoğlu Dilekçi's specialty?
Dr. Esra Nur Ademoğlu Dilekçi is a specialist in Endocrinology at Acibadem. For a personalised assessment, the Acibadem international patient team can review your medical history and reports and explain the suitable next steps.
Which hospital does Dr. Esra Nur Ademoğlu Dilekçi practise at?
Dr. Esra Nur Ademoğlu Dilekçi sees patients at Acibadem International Hospital in İstanbul. The international patient team can confirm current availability and help you plan a consultation or visit.
What languages can I use when consulting Dr. Esra Nur Ademoğlu Dilekçi?
Consultations with Dr. Esra Nur Ademoğlu Dilekçi are supported in Turkish and English. In addition, Acibadem provides multilingual coordination and interpreter support so international patients can communicate clearly throughout their care.
How can I book an appointment with Dr. Esra Nur Ademoğlu Dilekçi?
You can request an appointment with Dr. Esra Nur Ademoğlu Dilekçi using the appointment form on this page, or by contacting the Acibadem international patient team by phone or WhatsApp. After you share your details, the team checks availability and confirms your appointment, usually within 24 hours.
Is an online video consultation available with Dr. Esra Nur Ademoğlu Dilekçi?
Yes. Dr. Esra Nur Ademoğlu Dilekçi offers online video consultations, so you can discuss your condition and reports with the specialist before making any travel arrangements. The international patient team can help you schedule a secure video visit.
How many years of experience does Dr. Esra Nur Ademoğlu Dilekçi have?
Dr. Esra Nur Ademoğlu Dilekçi has around 27 years of professional experience in Endocrinology. A summary of education, experience and professional memberships is available on this page.
Can international patients arrange treatment with Dr. Esra Nur Ademoğlu Dilekçi?
Yes. Acibadem supports international patients end to end — from the first consultation and treatment planning through appointment scheduling, interpretation during the stay and follow-up after returning home. Sharing your case for an initial assessment is free of charge.
How do I get a second opinion involving Dr. Esra Nur Ademoğlu Dilekçi?
You can request an independent review of your diagnosis and proposed treatment. Share your medical reports through the consultation or "Ask a Doctor" form on this site, and the team will arrange a specialist review and explain the available options.
Care without borders

A dedicated team, from first message to follow-up

Our international patient office coordinates your appointment, travel and treatment across the Acıbadem network — including 7 JCI-accredited hospitals — and stays with you in your own language, every step of the way.

Book an Appointment

Schedule your appointment with Prof. Dr. Esra Nur Ademoğlu Dilekçi

Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.

  1. 1
    Choose your date & timePick a preferred day and time slot for your visit.
  2. 2
    Share your detailsTell us how to reach you and anything we should know.
  3. 3
    We confirm with youOur team confirms the appointment by phone or email.
Appointment Request

Request your appointment

This request goes directly to this doctor’s schedule.

Prof. Dr. Esra Nur Ademoğlu Dilekçi Appointment with Esra Nur Ademoğlu Dilekçi Endocrinology

Your information stays strictly confidential and is used only to arrange your care.

Where

Hospitals

Departments

Medical Units

Treatments

Treatments Performed

Patient Voices

What patients say about Prof. Dr. Esra Nur Ademoğlu Dilekçi

★★★★★From 2,400+ verified patient reviews
★★★★★ Verified Patient

“My endocrine consultation was handled with real skill and genuine care. Assoc. Prof. Dr. Dilekçi was honest about my options instead of pushing treatment. I would recommend this team to anyone.”

Noura A. · United Arab Emirates January 2025
★★★★★ Verified Patient

“Assoc. Prof. Dr. Dilekçi fine-tuned my treatment and my blood sugar is steady for the first time in years.”

Omar K. · Qatar January 2026
We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.